John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity 13D and 13G filings for Telomir Pharmaceuticals, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-18 6:48 pm Purchase | 2025-09-09 | 13G | Telomir Pharmaceuticals, Inc. Common Stock TELO | John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity | 1,774,900 5.500% | 1,774,900 (New Position) | Filing |